These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 12921484)

  • 21. Immunogenicity of quadrivalent HPV and combined hepatitis A and B vaccine when co-administered or administered one month apart to 9-10 year-old girls according to 0-6 month schedule.
    Gilca V; Sauvageau C; Boulianne N; De Serres G; Couillard M; Krajden M; Ouakki M; Murphy D; Trevisan A; Dionne M
    Hum Vaccin Immunother; 2014; 10(8):2438-45. PubMed ID: 25424952
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combining hepatitis A and B vaccination in children and adolescents.
    Van Damme P; Van der Wielen M
    Vaccine; 2001 Mar; 19(17-19):2407-12. PubMed ID: 11257370
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibody persistence and immune memory 4 years post-vaccination with combined hepatitis A and B vaccine in adults aged over 40 years.
    Chlibek R; von Sonnenburg F; Van Damme P; Smetana J; Tichy P; Gunapalaiah B; Leyssen M; Jacquet JM
    J Travel Med; 2011; 18(2):145-8. PubMed ID: 21366801
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunogenicity, effectiveness and safety of combined hepatitis A and B vaccine: a systematic literature review.
    Bakker M; Bunge EM; Marano C; de Ridder M; De Moerlooze L
    Expert Rev Vaccines; 2016 Jul; 15(7):829-51. PubMed ID: 26840060
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A two dose schedule for combined hepatitis A and hepatitis B vaccination in children ages one to eleven years.
    Van Der Wielen M; Van Damme P; Collard F
    Pediatr Infect Dis J; 2000 Sep; 19(9):848-53. PubMed ID: 11001108
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Two-dose combined vaccination against hepatitis A and B in healthy subjects aged 11-18 years.
    Van Herck K; Van Damme P; Collard F; Thoelen S
    Scand J Gastroenterol; 1999 Dec; 34(12):1236-40. PubMed ID: 10636072
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A randomized clinical trial of immunization with combined hepatitis A and B versus hepatitis B alone for hepatitis B seroprotection in hemodialysis patients.
    Tung J; Carlisle E; Smieja M; Kim PT; Lee CH
    Am J Kidney Dis; 2010 Oct; 56(4):713-9. PubMed ID: 20630640
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Comparison of immunogenicity and safety of Engerix B and Twinrix vaccine].
    Gałaj A; Grześk G; Borys D; Durmowicz A; Grześk E; Szadujkis-Szadurski L
    Wiad Lek; 2004; 57(5-6):217-20. PubMed ID: 15518064
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Randomized Controlled Trial to Evaluate a Potential Hepatitis B Booster Vaccination Strategy Using Combined Hepatitis A and B Vaccine.
    Li F; Hu Y; Zhou Y; Chen L; Xia W; Song Y; Tan Z; Gao L; Yang Z; Zeng G; Han X; Li J; Li J
    Pediatr Infect Dis J; 2017 May; 36(5):e157-e161. PubMed ID: 28060048
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Can monovalent hepatitis A and B vaccines be replaced by a combined hepatitis A/B vaccine during the primary immunization course?
    Kallinowski B; Knöll A; Lindner E; Sänger R; Stremmel W; Vollmar J; Zieger B; Jilg W
    Vaccine; 2000 Aug; 19(1):16-22. PubMed ID: 10924782
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long term (24 months) follow-up of a hepatitis A and B vaccine, comparing a two and three dose schedule in adolescents aged 12-15 years.
    Levie K; Beran J; Collard F; Nguyen C
    Vaccine; 2002 Jun; 20(19-20):2579-84. PubMed ID: 12057615
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Immunogenicity of vaccines against viral hepatitis A and B in the population above 40 years of age -- impact of risk factors].
    Chlíbek R; Smetana J; Sindelár R; Cecetková B; Prymula R; Kohl I
    Epidemiol Mikrobiol Imunol; 2007 Aug; 56(3):119-28. PubMed ID: 17900060
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The immunological effectiveness and reactogenicity of the vaccine "HEP-A+B-in-VAC" against hepatitis A and B].
    Chuĭkova KI; Gordetskaia EL; Gorbunov MA; Maĭdaniuk AG; Pomytkina MI
    Vopr Virusol; 2006; 51(1):31-3. PubMed ID: 16515040
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reactogenicity and immunogenicity profile of a two-dose combined hepatitis A and B vaccine in 1-11-year-old children.
    Roberton D; Marshall H; Nolan TM; Sokal E; Díez-Domingo J; Flodmark CE; Rombo L; Lewald G; Flor Jde L; Casanovas JM; Verdaguer J; Marés J; Esso DV; Dieussaert I; Stoffel M
    Vaccine; 2005 Oct; 23(43):5099-105. PubMed ID: 16055231
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunogenicity of Twinrix in older adults: a critical analysis.
    Stoffel M; Lievens M; Dieussaert I; Martin I; André F
    Expert Rev Vaccines; 2003 Feb; 2(1):9-14. PubMed ID: 12901592
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of Accelerated and Standard Hepatitis B Vaccination Schedules in High-Risk Healthy Adults: A Meta-Analysis of Randomized Controlled Trials.
    Jin H; Tan Z; Zhang X; Wang B; Zhao Y; Liu P
    PLoS One; 2015; 10(7):e0133464. PubMed ID: 26196903
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combined two-dose hepatitis A and B vaccine (AmBirix).
    Jarvis B; Figgitt DP
    Drugs; 2003; 63(2):207-13; discussion 214-5. PubMed ID: 12515566
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunity to hepatitis A and B persists for at least 15 years after immunisation of adolescents with a combined hepatitis A and B vaccine.
    Beran J; Van Der Meeren O; Leyssen M; D'silva P
    Vaccine; 2016 May; 34(24):2686-91. PubMed ID: 27105563
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combined hepatitis A and B vaccines: a review of their immunogenicity and tolerability.
    Murdoch DL; Goa K; Figgitt DP
    Drugs; 2003; 63(23):2625-49. PubMed ID: 14636084
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adherence to hepatitis A and hepatitis B multi-dose vaccination schedules among adults in the United Kingdom: a retrospective cohort study.
    Johnson KD; Lu X; Zhang D
    BMC Public Health; 2019 Apr; 19(1):404. PubMed ID: 30987613
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.